Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Health Canada approved Celystra Pharma’s Dawnzera for preventing hereditary angioedema attacks; the company expects it to become commercially available in Canada in coming months.
Celystra Pharma Health Canada Has Approved Dawnzera(Tm) For Prevention Of Hereditary Angioedema Attacks